BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Cleverson T. Soares, Luciana R. V. Fachin, Ana P. F. Trombone, Patricia S. Rosa, Cássio C. Ghidella, Andrea F. F. Belone. Potential of AKR1B10 as a Biomarker and Therapeutic Target in Type 2 Leprosy ReactionFrontiers in Medicine 2018; 5 doi: 10.3389/fmed.2018.00263
2
Xu Ye, Cunyan Li, Xuyu Zu, Minglin Lin, Qiang Liu, Jianghua Liu, Guoguo Xu, Zhiyong Chen, Yongliang Xu, Long Liu, Diteng Luo, Zhe Cao, Guiyuan Shi, Zirui Feng, Hongyu Deng, Qianjin Liao, Chuan Cai, Duan‐Fang Liao, Jing Wang, Junfei Jin, Deliang Cao. A Large‐Scale Multicenter Study Validates Aldo‐Keto Reductase Family 1 Member B10 as a Prevalent Serum Marker for Detection of Hepatocellular CarcinomaHepatology 2019;  doi: 10.1002/hep.30519
3
Johanna DiStefano, Bethany Davis. Diagnostic and Prognostic Potential of AKR1B10 in Human Hepatocellular CarcinomaCancers 2019; 11(4): 486 doi: 10.3390/cancers11040486
4
Junqing Wang, Yunyun Zhou, Xiaochun Fei, Xuehua Chen, Yongjun Chen. Biostatistics mining associated method identifies AKR1B10 enhancing hepatocellular carcinoma cell growth and degenerated by miR-383-5pScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-29271-3